𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories

✍ Scribed by Cheng, Lei; Ren, Wei; Xie, Li; Li, Ming; Liu, Jiang; Hu, Jing; Liu, Bao-Rui; Qian, Xiao-Ping


Book ID
125344325
Publisher
Springer
Year
2014
Tongue
English
Weight
296 KB
Volume
74
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Activation of signal pathways and the re
✍ Jiezhong Chen; Xu-Feng Huang; Andrew Katsifis πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 1 views

## Abstract Colorectal cancer is the third most common cancer with a 5‐year survival rate of less than 10%. It is caused by alterations of multiple signal pathways which are affected by both genetic and environmental factors. In some cases, EGFR is important in the carcinogenesis of colorectal canc